Literature DB >> 2666580

PET and movement disorders.

D J Brooks1, R S Frackowiak.   

Abstract

In this paper the use of PET for determining the patterns of disruption of both regional cerebral metabolism, and the pre- and post-synaptic dopaminergic systems, associated with movement disorders is reviewed. That the various akinetic-rigid syndromes result in distinctive PET findings is shown, making functional imaging valuable in their differential diagnosis. PET may also be useful for detecting the presence of sub-clinical disease in Huntington's disease and other inherited movement disorders.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666580      PMCID: PMC1033310          DOI: 10.1136/jnnp.52.suppl.68

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

1.  Regional blood flow in hemiparkinsonism.

Authors:  J S Perlmutter; M E Raichle
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

2.  Pre-synaptic and post-synaptic dopaminergic system in human brain.

Authors:  K L Leenders; S Herold; D J Brooks; A J Palmer; D Turton; G Firnau; E S Garnett; C Nahmias; N Veall
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

3.  Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography.

Authors:  G Rosenthal; S Gilman; R A Koeppe; K J Kluin; D S Markel; L Junck; S S Gebarski
Journal:  Ann Neurol       Date:  1988-09       Impact factor: 10.422

4.  The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.

Authors:  K L Leenders; L Wolfson; J M Gibbs; R J Wise; R Causon; T Jones; N J Legg
Journal:  Brain       Date:  1985-03       Impact factor: 13.501

5.  Metabolic effects of unilateral lesion of the substantia nigra.

Authors:  G F Wooten; R C Collins
Journal:  J Neurosci       Date:  1981-03       Impact factor: 6.167

6.  Pure hemidystonia with basal ganglion abnormalities on positron emission tomography.

Authors:  J S Perlmutter; M E Raichle
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

7.  Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography.

Authors:  E S Garnett; C Nahmias; G Firnau
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

8.  Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.

Authors:  F J Williams; J M Walshe
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

9.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

Authors:  L I Wolfson; K L Leenders; L L Brown; T Jones
Journal:  Neurology       Date:  1985-10       Impact factor: 9.910

10.  Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.

Authors:  D E Kuhl; M E Phelps; C H Markham; E J Metter; W H Riege; J Winter
Journal:  Ann Neurol       Date:  1982-11       Impact factor: 10.422

View more
  2 in total

Review 1.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

2.  HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.

Authors:  H S Markus; D C Costa; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.